-
MindMed Names Robert Barrow As CEO & Director, Announces Management Shake-Ups
Tuesday, December 14, 2021 - 11:24am | 678Psychedelic-focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) announced Tuesday that Robert Barrow has been appointed CEO and member of the board of directors. Barrow, an accomplished pharmaceutical executive and a recognized leader in the psychedelic industry, is...
-
FDA Shows Support For Development Of MindMed's Session Monitoring System
Thursday, December 9, 2021 - 11:23am | 448Psychedelic-focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) recently met with the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) with consultation from the Center for Drug Evaluation and Research (CDER) to discuss several...